E1399. Impact of FDG PET CT on Management Decisions in Endometrial and Cervical Malignancies: A Case-Based, Multimodality Pictorial Review
Authors
Miguel Ibarra Lopez;
Rush University Medical Center
Pokhraj Suthar;
Rush University Medical Center
Sumeet Virmani ;
Rush University Medical Center
Background
18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) is used for cancer staging, treatment planning, and tumor surveillance. It is most helpful when dealing with highly metabolic lesions found in various anatomical regions. FDG PET-CT plays an ever-growing role in gynecological cancers of the cervix and endometrium, where early nodal and distal metastasis can alter treatment plans and prognostic value.
Educational Goals / Teaching Points
This case-based pictorial review focuses on the spectrum of imaging findings on FDG PET-CT with cervical and endometrial cancer that had a big impact/altered patient management. Multimodality correlative imaging is provided where available.
Key Anatomic/Physiologic Issues and Imaging Findings/Techniques
In this exhibit, we present 15 interesting cases with multimodality correlation that highlights the importance of FDG PET-CT in gynecological cancers of the endometrium and cervix.
Conclusion
FDG PET CT plays an important in the management of patients with cervical and endometrial malignancies. Its ever-increasing role in gynecological malignancies can provide the treatment team with better diagnostic and prognostic information that many times alters the treatment plan as compared to conventional imaging.
